Bristol-Myers Squibb to Take Part in Leerink 6th Annual Global Health Care Conference

02/08/2017

Bristol-Myers Squibb Company (NYSE:BMY) will take part in the Leerink Annual Global Health Care Conference on Wednesday, February 15, 2017, in New York. Murdo Gordon, executive vice president and chief commercial officer, will answer questions about the company at 3:30 p.m. EST.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.

Bristol-Myers SquibbMedia:Ken Dominski, 609-252-5251 ken.dominski@bms.com orInvestors:Tim Power, 609-252-7509 timothy.power@bms.com orBill Szablewski, 609-252-5894 william.szablewski@bms.com

Multimedia Files:

Categories: Press Releases